Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation

Radiother Oncol. 2002 Oct;65(1):9-16. doi: 10.1016/s0167-8140(02)00173-1.

Abstract

Background and purpose: Sensori-neural hearing loss (SNHL) is a common complication to radiation therapy in the upper head and neck region. In this study, we estimated the dose response relationship for SNHL with adjustment for pre-therapeutic risk factors.

Patients and methods: The pre- and post-therapeutic hearing levels were recorded in a previously published study of 20 patients receiving radiotherapy for nasopharyngeal carcinoma. In the present study, the dose to the inner ear of these patients was estimated with a computed tomography (CT) based treatment planning system. CT data from a 'proxy patient' were used for patients with no available CT scan. SNHL was analyzed as a function of radiation dose and potential risk factors were tested.

Results: The incidence of SNHL increased significantly with increasing dose to the cochlea. Increasing patient's age, and decreasing pre-therapeutic hearing level were statistically significantly associated with an increased risk of SNHL. A nomogram is presented for estimating individualized dose constraints of potential use in treatment planning.

Conclusions: The inner ear is a critical structure in patients with nasopharyngeal carcinoma and the dose to the inner ear should be carefully considered when planning radiation treatment in this region.

MeSH terms

  • Adult
  • Aged
  • Brain Stem / radiation effects
  • Dose-Response Relationship, Radiation
  • Ear, Inner / radiation effects*
  • Female
  • Hearing Loss, Sensorineural / etiology*
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Parotid Gland / radiation effects
  • Patient Care Planning
  • Pituitary Gland / radiation effects
  • Radiation Injuries / etiology*
  • Risk Assessment